IRS Issues Final Rule Implementing Medical Device Excise Tax

The Internal Revenue Service released a

implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.

Related Resources

Case Studies
Overview
Guides/Reports
In 2015, AHRMM convened the AHRMM Thought Leader Task Force, an exploratory group tasked with uncovering applications of the
White Papers
This paper addresses the importance of the supply chain on overall health care costs and how transparent data can lead to a best practice sup
White Papers
A review of inventory distribution methods utilized throughout health care including advantages, disadvantages, and considerations of best practice
Case Studies
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
The following leading practice describes methods used to reduce Hospital Acquired Pressure Ulcers (HAPU).